Congratulations to our start-up Ebenbuild GmbH (https://www.ebenbuild.com/) that was able to secure its seed financing round. Alongside lead investors High-Tech Gründerfonds and Bayern Kapital, the venture and growth capital organization of the state of Bavaria, a number of well-known business angels also invested in the Munich-based HealthTech start-up, with the funding amounting to €2.5 million. Ebenbuild develops personalized lung simulation models based on patient data. These “digital twins” are then used to improve treatment outcomes for ICU patients suffering from ARDS, or acute respiratory distress syndrome, who are on ventilators.

More details can be found in the official press release of HTGF at https://www.htgf.de/en/htgf-seed-investment-ebenbuild/ or at https://www.linkedin.com/feed/update/urn:li:activity:6915212865041764352.